AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (Q65375547)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) |
clinical trial |
Statements
A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (English)
0 references
18 April 2011
0 references
29 August 2014
0 references
223
0 references
18 year
0 references